Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Neuropathy
100%
IGF1R Signaling
100%
Dapagliflozin
100%
Diabetic Neuropathy
85%
Sciatic Nerve
57%
Brain Nerve
57%
Wistar Rats
28%
Signaling Molecules
28%
IGF Signaling
28%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
28%
Neuroprotective Potential
28%
Quantitative PCR
14%
Immunohistochemistry
14%
Expression Level
14%
AKT1
14%
Western Blotting
14%
Decreased Expression
14%
Altered Expression
14%
Expression Analysis
14%
Neuroprotective Effect
14%
Structural Change
14%
Histological Study
14%
Behavioral Parameters
14%
Behavioral Tests
14%
Renoprotection
14%
Cardio
14%
Diabetic Treatment
14%
Histopathology
14%
Extraglycemic Effects
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathy
100%
Dapagliflozin
100%
Maturity Onset Diabetes of the Young
100%
Diabetic Neuropathy
85%
Neuroprotective Agent
42%
Wistar Rat
28%
Sodium Glucose Cotransporter 2 Inhibitor
28%
Western Blot
14%
Protein Kinase B
14%
Rat
14%
Neuroscience
Neuropathy
100%
Dapagliflozin
100%
Diabetic Neuropathy
85%
Sciatic Nerve
57%
Neuroprotective Agent
42%
Immunohistochemistry
14%
Western Blot
14%
Cell Signaling
14%
Expression Analysis
14%
Protein Kinase B
14%
Histopathology
14%
Behavioral Test
14%
Veterinary Science and Veterinary Medicine
Neuropathy
100%
Diabetic Neuropathy
100%
Maturity Onset Diabetes of the Young
100%
Sciatic Nerve
66%
Rat
50%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Immunohistochemistry
16%
Histopathology
16%